Security key
761152107
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 145,776,137
- Total 13F shares
- 96,981,394
- Share change
- +4,343,537
- Total reported value
- $23,361,502,028
- Put/Call ratio
- 339%
- Price per share
- $240.87
- Number of holders
- 940
- Value change
- +$1,010,595,349
- Number of buys
- 402
- Number of sells
- 439
Report period
Q4 2025
Institutions
940
Top holders
10
RMD full security history
Newer quarter: Q1 2026
Previous quarter: Q3 2025
RESMED INC SEC filings
RESMED INC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 761152107
Recent filing periods:
Top shareholders of RMD - RESMED INC - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Justin Leong |
3/4/5
|
Chief Product Officer |
0.02%
|
29,028
|
$7,699,967 | — | 20 Nov 2025 | |
| Ronald R. Taylor |
3/4/5
|
Director |
0.02%
|
24,771
|
$6,570,755 | — | 20 Nov 2025 | |
| Kaushik Ghoshal |
3/4/5
|
Chief Commercial Officer, SaaS |
0.01%
|
19,430
|
$4,985,543 | — | 05 Aug 2025 | |
| Carol J. Burt |
3/4/5
|
Director |
0.01%
|
18,816
|
$4,991,131 | — | 20 Nov 2025 | |
| Richard Sulpizio |
3/4/5
|
Director |
0.01%
|
17,796
|
$4,720,566 | — | 19 Nov 2025 | |
| Harjit Gill |
3/4/5
|
Director |
0.01%
|
10,940
|
$2,901,944 | — | 20 Nov 2025 | |
| Karen Drexler |
3/4/5
|
Director |
0.01%
|
10,602
|
$2,812,286 | — | 20 Nov 2025 | |
| Desney Tan |
3/4/5
|
Director |
0%
|
6,002
|
$1,592,090 | — | 20 Nov 2025 | |
| John Hernandez |
3/4/5
|
Director |
0%
|
5,118
|
$1,357,600 | -$739,289 | 20 Nov 2025 | |
| Jan de Witte |
3/4/5
|
Director |
0%
|
4,261
|
$1,086,555 | -$645,897 | 25 Nov 2025 | |
| Christopher DelOrefice |
3/4/5
|
Director |
0%
|
2,423
|
$642,724 | — | 20 Nov 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
13%
|
19,040,440
|
$5,211,939,642 | — | 30 Sep 2025 | |
| BlackRock, Inc. |
13F
|
Company |
8.4%
|
12,277,966
|
$3,360,847,519 | — | 30 Sep 2025 | |
| STATE STREET CORP |
13F
|
Company |
4.5%
|
6,549,164
|
$1,792,702,662 | — | 30 Sep 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
3.1%
|
4,552,916
|
$1,246,269,745 | — | 30 Sep 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.9%
|
4,251,688
|
$1,159,544,500 | — | 30 Sep 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.6%
|
2,313,138
|
$633,175,806 | — | 30 Sep 2025 | |
| Invesco Ltd. |
13F
|
Company |
1.4%
|
2,108,763
|
$577,231,572 | — | 30 Sep 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.2%
|
1,697,882
|
$464,761,240 | — | 30 Sep 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.73%
|
1,067,643
|
$292,245,918 | — | 30 Sep 2025 | |
| Legal & General Group Plc |
13F
|
Company |
0.66%
|
958,210
|
$262,290,821 | — | 30 Sep 2025 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.62%
|
906,744
|
$248,203,036 | — | 30 Sep 2025 | |
| FMR LLC |
13F
|
Company |
0.6%
|
880,306
|
$240,965,941 | — | 30 Sep 2025 | |
| UBS Group AG |
13F
|
Company |
0.6%
|
873,530
|
$239,111,367 | — | 30 Sep 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.59%
|
860,791
|
$235,624,329 | — | 30 Sep 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.58%
|
846,134
|
$231,586,653 | — | 30 Sep 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.56%
|
823,624
|
$225,450,507 | — | 30 Sep 2025 | |
| NORDEA INVESTMENT MANAGEMENT AB |
13F
|
Company |
0.54%
|
790,872
|
$217,386,987 | — | 30 Sep 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.53%
|
772,187
|
$211,372,000 | — | 30 Sep 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.48%
|
706,369
|
$193,354,000 | — | 30 Sep 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.43%
|
625,528
|
$171,225,780 | — | 30 Sep 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.42%
|
617,464
|
$169,027,458 | — | 30 Sep 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.4%
|
579,632
|
$158,662,667 | — | 30 Sep 2025 | |
| CAISSE DE DEPOT ET PLACEMENT DU QUEBEC |
13F
|
Company |
0.39%
|
565,901
|
$154,904,079 | — | 30 Sep 2025 | |
| Swedbank AB |
13F
|
Company |
0.37%
|
542,711
|
$148,556,281 | — | 30 Sep 2025 | |
| CAPTRUST FINANCIAL ADVISORS |
13F
|
Company |
0.37%
|
537,623
|
$147,163,581 | — | 30 Sep 2025 | |
| Tandem Investment Advisors, Inc. |
13F
|
Company |
0.35%
|
505,216
|
$138,293,000 | — | 30 Sep 2025 | |
| FIL Ltd |
13F
|
Company |
0.32%
|
466,991
|
$127,829,446 | — | 30 Sep 2025 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.31%
|
445,198
|
$121,864,093 | — | 30 Sep 2025 | |
| Swiss National Bank |
13F
|
Company |
0.29%
|
422,700
|
$115,705,671 | — | 30 Sep 2025 | |
| Amundi |
13F
|
Individual |
0.27%
|
391,141
|
$110,050,528 | — | 30 Sep 2025 | |
| LOS ANGELES CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.26%
|
384,788
|
$105,328,019 | — | 30 Sep 2025 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
0.26%
|
377,056
|
$103,211,539 | — | 30 Sep 2025 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.25%
|
367,932
|
$100,714,026 | — | 30 Sep 2025 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.25%
|
360,517
|
$98,684,319 | — | 30 Sep 2025 | |
| AustralianSuper Pty Ltd |
13F
|
Company |
0.25%
|
357,485
|
$97,854,369 | — | 30 Sep 2025 | |
| Allianz Asset Management GmbH |
13F
|
Company |
0.25%
|
357,421
|
$97,836,850 | — | 30 Sep 2025 | |
| WELCH & FORBES LLC |
13F
|
Company |
0.23%
|
329,836
|
$90,286,154 | — | 30 Sep 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.22%
|
318,937
|
$87,302,490 | — | 30 Sep 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.21%
|
310,987
|
$85,126,471 | — | 30 Sep 2025 |
Institutional Holders of RESMED INC - Common Stock (RMD) as of Q4 2025
As of 31 Dec 2025,
RESMED INC - Common Stock (RMD) was held by
940 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
96,981,394 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock, Inc., STATE STREET CORP, Bank of New York Mellon Corp, GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, Invesco Ltd., NORTHERN TRUST CORP, FIRST TRUST ADVISORS LP, and DEUTSCHE BANK AG\.
This page lists
940
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
939
Q4 2025 holders
940
Holder diff
1
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q4 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.